Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK non-small cell lung cancer
Preprint in Research Square (March 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Preprint in Research Square (March 2024)
Article in American Journal of Clinical Oncology (February 2024)
Article in Frontiers in Immunology (December 2023)